REYNO LEONARD — SEC Form 4 filings
SEC reporting owner CIK 1528716. 8 Form 4 filings on record with FilingPulse; latest filed 2026-07-13.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-02-15 to 2026-07-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 10,000 shares, $22,200 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 14.
- Largest priced transaction: sale of 10,000 shares @ $2.22 ($22,200) in C4 Therapeutics, Inc., filed 2026-01-16.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | Chief Medical Officer | 8 | — | 1 leg · 10,000 sh · $22,200 | 14 |
Form 4 filings — REYNO LEONARD
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-13 | 4 | C4 Therapeutics, Inc. (CCCC) | Option exercise (M): 15,325 @ $0 · Tax withholding (F): 7,397 @ $4.06 | EDGAR |
| 2026-02-18 | 4 | C4 Therapeutics, Inc. (CCCC) | Grant/award (A): 240,000 @ $0 · Option exercise (M): 30,950 @ $0 · Tax withholding (F): 16,579 @ $1.89 | EDGAR |
| 2026-01-16 | 4 | C4 Therapeutics, Inc. (CCCC) | Sale (S): 10,000 @ $2.22 | EDGAR |
| 2025-07-15 | 4/A | C4 Therapeutics, Inc. (CCCC) | Option exercise (M): 15,325 @ $0 · Tax withholding (F): 7,382 @ $1.99 | EDGAR |
| 2025-07-14 | 4 | C4 Therapeutics, Inc. (CCCC) | Tax withholding (F): 7,382 @ $1.99 | EDGAR |
| 2025-02-18 | 4 | C4 Therapeutics, Inc. (CCCC) | Grant/award (A): 87,100 @ $0 · Tax withholding (F): 5,145 @ $3.18 · Grant/award (A): 130,600 (derivative) @ $0 | EDGAR |
| 2024-07-11 | 4 | C4 Therapeutics, Inc. (CCCC) | Tax withholding (F): 6,191 @ $5 | EDGAR |
| 2024-02-15 | 4 | C4 Therapeutics, Inc. (CCCC) | Grant/award (A): 36,700 @ $0 · Grant/award (A): 165,300 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1528716 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →